RxDoctor Payments Data

Edward Harding, MD

Family Medicine · Pahrump, NVNPI 1871556415

Payments from drug & device makers

$632in general payments, 2019–2025

Across 40 payments — averaging $15.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$178
  • Boehringer Ingelheim$66
  • Exact Sciences$48
  • Amgen$46
  • E.r. Squibb & Sons, L.L.C.$44
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$38
  • plus $210 from 10 others

What the payments were for

  • Food & beverage$632100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$632 in reported general payments places this provider in the 60th percentile of 902 family medicine providers in Nevada.

See all family medicine providers in Nevada

Medicare billing

Part B allowed, 2024
$109,528
Medicare patients
319
Services billed
1,079

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban129$145,556
OzempicSemaglutide69$91,160
XareltoRivaroxaban48$66,069
JardianceEmpagliflozin42$56,958
TrulicityDulaglutide15$39,292
JanuviaSitagliptin Phosphate23$33,602
FarxigaDapagliflozin Propanediol15$17,235
MyrbetriqMirabegron13$14,630
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog21$14,588
Fluticasone-SalmeterolFluticasone Propion/Salmeterol21$6,599
Lantus SolostarInsulin Glargine,hum.Rec.Anlog28$5,835
Atorvastatin Calcium632$5,227
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen170$4,309
Novolin 70-30 FlexpenInsulin Nph Hum/Reg Insulin Hm28$4,060
Levothyroxine Sodium431$4,048

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$30$145,556129 claims
Novo NordiskOzempic$36$91,16069 claims
Johnson & JohnsonXarelto$16$66,06948 claims
Boehringer IngelheimJardiance$66$56,95842 claims
Lilly USA, LLCTrulicity$15$39,29215 claims
AstraZenecaFarxiga$178$17,23515 claims
Astellas Pharma US IncMyrbetriq$16$14,63013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 902 family medicine providers in Nevada.

Other family medicine in Pahrump

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →